Health Care/Hospital

Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome

CASTRES, France, April 26, 2024 /PRNewswire/ -- Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSA™ (vibegron under the international non-propriet...

2024-04-26 23:46 550

United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%

Along with the publication of its 2023 annual report and the Q1 2024 report, United Imaging Healthcare released its ESG report. SHANGHAI, April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, h...

2024-04-26 23:00 563

United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™

SHANGHAI, April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility, intern...

2024-04-26 23:00 587

New President Appointed for Nitto Denko Avecia Inc.

MILFORD, Mass., April 26, 2024 /PRNewswire/ -- Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of N...

2024-04-26 21:20 578

FOSUN FOR GOOD, CREATING IMPACT: Fosun International Issued its 2023 ESG Report and the Second Climate Information Disclosures Report

HONG KONG, April 26, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today issued the Environmental, Social and Governance (ESG) Report 2023 (the "ESG Report"). Facing the increasingly sever...

2024-04-26 19:34 714

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

KYOTO, Japan, April 26, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko,Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection, and ...

2024-04-26 16:00 750

Antengene Announces One Oral and Three Poster Presentations at ASCO 2024

* Oral session:ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in Phase II studies for cervical cancer * Three Poster presentations: Phase I/II studies for ATG-031 (anti-CD24 monoclonal antibody) and ATG-022 (Claudin 18.2 antibody-drug conjugate) and selinexor(XPO1 Inhibitor) SHANGHA...

2024-04-25 20:00 1080

Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD)

SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD)...

2024-04-25 19:57 1045

PolyU forms global partnership with ZEISS Vision Care to expand impact and accelerate market penetration of patented myopia control technology

HONG KONG, April 25, 2024 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, to expand the global impact and speed up the market penetration of PolyU's proprieta...

2024-04-25 17:23 978

Bazi Bushen Capsule Became the Representative Drug of Anti-aging Chinese Medicine

SHIJIAZHUANG, China, April 25, 2024 /PRNewswire/ -- On April 21, the 3rd Traditional Chinese Medicine Anti-Aging Conference, hosted by the World Federation of Chinese Medicine Societies, was held inShijiazhuang. Yiling Pharmaceutical'sBazi Bushen capsule, as a representative drug of anti-aging i...

2024-04-25 16:07 934

GSK Advocates Importance of Adult Immunisation amongst Malaysians

KUALA LUMPUR, Malaysia, April 25, 2024 /PRNewswire/ -- As Malaysia's population shifts towards an ageing demographic, the importance of adult immunisation becomes increasingly apparent. By ensuring that individuals receive necessary vaccinations, adults can remain active, be healthy participants ...

2024-04-25 14:53 887

United Imaging Healthcare Strengthens Partnership with MedikaBazaar for Indian Market Leadership

COLOMBO, Sri Lanka, April 25, 2024 /PRNewswire/ -- United Imaging, a global leader in healthcare innovations, recently hosted a meeting with MedikaBazaar in Colombo, Sri Lanka, to strategically reinforce their partnership. With a robust four-year collaboration resulting in over 300 installations a...

2024-04-25 12:14 931

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, April 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2024-04-25 10:02 1107

Esaote Group: Shareholders' Meeting approves financial statements as of 31 December 2023

* Consolidated revenues up to €273.2 million (+6.5%), EBITDA stands at  €41.7 million (+24.5%); EBIT up to €13.4 million and net profit up to €6.2 million. * Sales increased in all business lines, especially in the ultrasound segment (+9.7%). Second consecutive record sales year for MRI (+3.3%...

2024-04-24 18:00 1249

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved inEurope Conditional marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial ST. GALLEN, Switzerland and SAN DIEGO, April 24, 2024 /PR...

2024-04-24 15:00 1581

RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE

-       The choice is the individual's hand to treat oneself with love and care, where judgments and negative opinions have no place in personal beauty journeys. KUALA LUMPUR, Malaysia, April 24, 2024 /PRNewswire/ -- RELIFE, the dermatology and aesthetic medicine division of A. Menarini, a wholl...

2024-04-24 10:00 1193

LIFE360 ENHANCES FAMILY SAFETY APP WITH LAUNCH OF NEW FEATURES AND TIERED MEMBERSHIP BENEFITS IN AUSTRALIA AND NEW ZEALAND

The app adds emergency dispatch, data breach alerts, breakdown assistance, and more SYDNEY, April 24, 2024 /PRNewswire/ -- Leading family safety and location app Life360, has today announced the rollout of new safety features and enhancements through a triple-tier membership structure, offering ...

2024-04-24 05:00 1220

Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution

Advanced Intake™ demonstrates up to 65% efficiency gains in adverse case intake and 90% data extraction accuracy and quality BOSTON, April 23, 2024 /PRNewswire/ -- ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today revealed details about itsAdvanced Inta...

2024-04-23 20:00 1034

Ping An Reports RMB38,709 million of Operating Profit Attributable to Shareholders of the Parent Company in Q1 2024, Life & Health NBV grew 20.7% YoY

HONG KONG and SHANGHAI, April 23, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An," the "Company" or the "Group," HKEX: 2318; SSE: 601318) today announced its first quarter financial results for the three months endedMarch 31, 2024. China's economy grad...

2024-04-23 19:52 1946

Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets

Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain and quality management LONDON, April 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...

2024-04-23 19:00 1683
12345 ... 553